KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Short term Debt (2016 - 2025)

Labcorp Holdings (LH) has disclosed Short term Debt for 17 consecutive years, with $500.1 million as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 50.0% to $500.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $500.1 million through Dec 2025, down 50.0% year-over-year, with the annual reading at $500.1 million for FY2025, 50.0% down from the prior year.
  • Short term Debt hit $500.1 million in Q4 2025 for Labcorp Holdings, down from $1.0 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.0 billion in Q4 2024 to a low of $1.5 million in Q4 2021.
  • Historically, Short term Debt has averaged $560.6 million across 5 years, with a median of $500.1 million in 2025.
  • Biggest five-year swings in Short term Debt: crashed 99.6% in 2021 and later soared 19986.67% in 2022.
  • Year by year, Short term Debt stood at $1.5 million in 2021, then skyrocketed by 19986.67% to $301.3 million in 2022, then soared by 231.83% to $999.8 million in 2023, then increased by 0.05% to $1.0 billion in 2024, then crashed by 50.0% to $500.1 million in 2025.
  • Business Quant data shows Short term Debt for LH at $500.1 million in Q4 2025, $1.0 billion in Q4 2024, and $999.8 million in Q4 2023.